-
Caspofungin: Translational Lessons for Resistant Candida
2026-08-26
Caspofungin links fungal cell wall biology to practical translational strategy. By examining its mechanism, performance in a delayed-treatment Candida auris model, and role as a benchmark for emerging glucan-synthesis inhibitors, researchers can design more decision-relevant antifungal studies.
-
Entinostat: Separating Growth Arrest From Cell Death
2026-08-26
Entinostat (MS-275) is a selective class I HDAC inhibitor whose effects can be misread when viability and cell death are treated as equivalent. This guide combines target biology with dissertation-based assay principles to improve cancer response interpretation, including retinoblastoma and solid tumor research.
-
o-Agatoxin IVA in Cortical Excitotoxicity
2026-08-25
Lustig, Ahern, and Greenberg tested whether blocking P/Q-type voltage-gated calcium channels with ω-agatoxin IVA protects cultured cortical neurons from excitotoxic injury. The study found no reduction in LDH-defined toxicity after veratridine, ouabain, or NMDA challenges, showing that inhibition of glutamate release does not necessarily translate into neuronal protection.
-
Rotigotine Workflows for Dopaminergic Research
2026-08-25
Build more interpretable Parkinson’s disease and depression studies with Rotigotine, a dopamine D2/D3 receptor agonist that supports receptor, oxidative-stress, cellular, and behavioral readouts. This workflow emphasizes dose separation, exposure control, and locomotor-confound management so apparent antidepressant or neuroprotective effects are not mistaken for nonspecific stimulation.
-
Cyclophilin A and Cyclosporine Resistance in Mice
2026-08-24
The reference study used Ppia-deficient mice and immune cells to show that Cyclophilin A is the primary mediator of cyclosporine-mediated immunosuppression. Its genetic, cellular, and in vivo evidence connects drug resistance to reduced calcineurin inhibition and clarifies how Cyclosporin A blocks T-cell responses.
-
Milk EV Uptake in Porcine Intestinal Organoids
2026-08-24
This study establishes three porcine intestinal stem cell–based models to examine how milk-derived extracellular vesicles are internalized across intestinal regions and epithelial polarities. Its findings connect apical accessibility, extracellular vesicle uptake, and colon stemness-related responses while showing that endocytosis inhibitors suppress vesicle internalization.
-
ApexPrep DNA Plasmid Miniprep Kit for AML Research
2026-08-23
Build reliable plasmid DNA extraction for cloning, sequencing, and AML perturbation studies with one alkaline-lysis workflow for high- and low-copy vectors. The ApexPrep DNA Plasmid Miniprep Kit combines rapid membrane purification with practical checkpoints that help protect downstream digestion, transformation, sequencing, and robust-cell-line transfection.
-
NAT1–ENO1–Lactate Axis in Colorectal Cancer
2026-08-22
A 2026 MedComm study defines NAT1 as a metabolic–immune regulator that restrains ENO1 activity, lactate production, and TRAF6-dependent PD-L1 stabilization in colorectal cancer. Its integrated database, multi-omics, cellular, patient, and mouse-model evidence provides a mechanistic rationale for testing lactate-pathway perturbation alongside immune checkpoint blockade, while remaining preclinical.
-
Acifran Workflows for Lipid Signaling Research
2026-08-21
Acifran enables receptor-proximal studies of HCAR2/GPR109A and HCAR3/GPR109B signaling, linking cAMP responses to lipid metabolism phenotypes. This workflow-focused guide covers stock preparation, comparative receptor assays, structure-informed experiments, and practical troubleshooting.
-
Rapamycin in Obesity: An mTOR Assay Strategy
2026-08-20
Rapamycin (Sirolimus) can serve as a mechanistic probe for testing how mTOR signaling intersects with macrophage–adipose stem cell communication and ferroptosis. This article translates a recent obesity study into an assay strategy while defining what Rapamycin can—and cannot—prove.
-
Deferasirox Fe3+ Chelate: From Binding to Translation
2026-08-20
A mechanistic and translational framework for using Deferasirox Fe3+ chelate in iron overload treatment research, with practical guidance for beta-thalassemia, chronic anemia, assay design, and research reproducibility.
-
Dexamethasone for Inflammation Research
2026-08-19
Dexamethasone (DHAP) provides a defined glucocorticoid anti-inflammatory reference for modeling NF-κB activity, stem cell differentiation, osteosarcoma biology, and neuroinflammation. This guide translates a recent rosemary-root natural-product study into practical dose-response, control, and troubleshooting strategies.
-
Dacomitinib Workflows for ErbB and Ferroptosis Research
2026-08-19
Dacomitinib (PF-00299804) enables durable ErbB pathway perturbation in resistant lung and breast cancer models, while offering an exploratory bridge to mitochondrial ferroptosis research. This guide translates its pan-HER mechanism into practical dosing, signaling, cell-death, and troubleshooting workflows without overstating evidence from colorectal cancer studies.
-
Acifran: From GPCR Structure to Lipid Translation
2026-08-18
Structural biology is redefining how researchers evaluate hydroxycarboxylic acid receptor agonists. This thought-leadership analysis positions Acifran as a practical bridge between HCAR2/HCAR3 mechanism, cAMP validation, lipid signaling pathway modulation, and translational decision-making in metabolic disorder research.
-
Thiazovivin (A5506): Practical ROCK Inhibitor Guide
2026-08-18
Thiazovivin is a ROCK inhibitor used to address cell loss after hESC dissociation and to support fibroblast reprogramming during induced pluripotent stem cell generation. This guide provides product-specific handling and workflow controls while noting that it is for research use only, not for diagnostic, clinical, or medical applications.